Misocholic tablets for elevated liver enzymes
Treatments studied
Part of Digestive system clinical trials.
This trial tests a new medication called Misocholic to lower elevated liver enzymes in people with liver stress from alcohol, certain medications, or fatty liver disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your liver enzymes (ALT or AST) must be elevated at least 2 times but less than 5 times the normal upper limit.
- The elevated enzymes must be related to alcohol use, medication or supplements, or fatty liver disease.
- You must not have other significant liver diseases like hepatitis B or C.
- You must be willing to avoid extra liver-support supplements or medications during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication (efimosfermin alfa) for people with cirrhosis (liver scarring) caused by MASH, a type of fatty liver disease. It aims to see if the drug can help improve liver health.
This trial tests a new medicine called Efimosfermin Alfa for people with MASH (a fatty liver disease) and moderate liver scarring. It aims to see if the medicine can improve the liver condition.
This study tests an investigational drug called efimosfermin alfa to see if it is safe and tolerable for people who have liver scarring (F2 or F3 stage) from a condition called MASH. The goal is to find out if the drug can help without causing serious side effects.
This study is testing if a combination of four herbs (artichoke, milk thistle, turmeric, and licorice root) can help people with non-alcoholic mild to moderate fatty liver disease (also called metabolic-associated fatty liver disease). It's a randomized trial, meaning participants are assigned to either the herbal mix or a comparison group. This may offer a natural option to support liver health.
This trial tests a new experimental drug called OPK-88006 to see if it can help treat MASH, a serious liver condition linked to excess fat buildup. The study has two parts: one with healthy volunteers to check safety, and one with people who have signs of fatty liver disease.
This study tests how your body processes a new medication called miricorilant, designed to help people with fatty liver disease (MASH). You'll have liver scans or recent biopsy results and metabolic conditions like diabetes or high blood pressure.
Hear when a new Alcohol-related Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.